Premium
Kidney retransplantation from HLA ‐incompatible living donors: A single‐center study of 3rd/4th transplants
Author(s) -
Barnes James C.H.,
Goodyear Stephen J.,
Imray Caitlin E.A.,
Lam For Tai,
Kashi Habib S.,
Tan Lam Chin,
Higgins Robert,
Imray Christopher H.E.
Publication year - 2017
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.13104
Subject(s) - medicine , kidney , single center , kidney transplantation , surgery , transplantation , complication , panel reactive antibody , kidney transplant , renal function , urology
Background The demand for kidney retransplantation following graft failure is rising. Repeat transplantation is often associated with poorer outcomes due to both immunological and surgical challenges. The aim of this study was to compare surgical and functional outcomes of kidney retransplantation in recipients that had previously had at least two kidney transplants with a focus on those with antibody incompatibility. Methods We analyzed 66 patients who underwent renal transplantation at a single center between 2003 and 2011. Consecutive patients receiving their 3rd or 4th kidney were case‐matched with an equal number of 1st and 2nd transplants. Results Twenty‐two 3rd and 4th kidney transplants were matched with 22 first and 22 seconds transplants. Operative times and length of stay were equivalent between the subgroups. Surgical complication rates were similar in all groups (22.7% in 1st and 2nd transplants, and 27.2% in 3rd/4th transplants). There was no significant difference in patient or graft survival over 5 years. Graft function was similar between transplant groups at 1, 3, and 5 years. Conclusions Third and fourth kidney transplants can be performed safely with similar outcomes to 1st and 2nd transplants. Kidney retransplantation from antibody‐incompatible donors may be appropriate for highly sensitized patients.